RMTG (Regenerative Medical Technology Group) Days Payable: 28.90 (As of Mar. 2026) — 92% Below Median


What is Regenerative Medical Technology Group Days Payable?

Regenerative Medical Technology Group RMTG -35.87% Days Payable is 28.90 as of Mar. 2026, which is 92% below its 10-year median of 352.96. The stock has 4 warning signs investors should review. Among 704 Biotechnology companies, Regenerative Medical Technology Group ranks worse than 71.45% on this metric.

Regenerative Medical Technology Group's average Accounts Payable for the three months ended in Mar. 2026 was $0.28 Mil. Regenerative Medical Technology Group's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.87 Mil. Hence, Regenerative Medical Technology Group's Days Payable for the three months ended in Mar. 2026 was 28.90.

The historical rank and industry rank for Regenerative Medical Technology Group's Days Payable or its related term are showing as below:

RMTG' s Days Payable Range Over the Past 10 Years
Min: 44.42   Med: 352.96   Max: 26864
Current: 44.42

During the past 9 years, Regenerative Medical Technology Group's highest Days Payable was 26864.00. The lowest was 44.42. And the median was 352.96.

RMTG's Days Payable is ranked worse than
71.45% of 704 companies
in the Biotechnology industry
Industry Median: 113.56 vs RMTG: 44.42

Regenerative Medical Technology Group's Days Payable declined from Mar. 2025 (126.23) to Mar. 2026 (28.90). It may suggest that Regenerative Medical Technology Group accelerated paying its suppliers.

Regenerative Medical Technology Group Days Payable Related Terms

Regenerative Medical Technology Group Days Payable Historical Data

* Premium members only.

The historical data trend for Regenerative Medical Technology Group's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerative Medical Technology Group Days Payable Chart

Regenerative Medical Technology Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only 352.96 119.06 165.59 140.00 72.71

Regenerative Medical Technology Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 126.23 89.19 34.81 39.47 28.90

RMTG vs PTIX, CERO, EMMA: Days Payable Comparison

For the Biotechnology subindustry, Regenerative Medical Technology Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerative Medical Technology Group Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenerative Medical Technology Group's Days Payable distribution charts can be found below:

* The bar in red indicates where Regenerative Medical Technology Group's Days Payable falls into.


Regenerative Medical Technology Group Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Regenerative Medical Technology Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.564 + 0.348) / 2 ) / 2.289*365
=0.456 / 2.289*365
=72.71

Regenerative Medical Technology Group's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0.348 + 0.205) / 2 ) / 0.873*365 / 4
=0.2765 / 0.873*365 / 4
=28.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 28.90 mean?
Regenerative Medical Technology Group (RMTG) has a Days Payable of 28.90 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Regenerative Medical Technology Group and its competitors. This is 92% below median its historical median of 352.96. Over the past decade, Regenerative Medical Technology Group's Days Payable has ranged from 44.42 to 26,864.00. According to the industry distribution chart, Regenerative Medical Technology Group ranks #503 out of 704 companies in the Biotechnology industry, placing it in the top 71.4%.
Is Regenerative Medical Technology Group's Days Payable too high?
Regenerative Medical Technology Group's current Days Payable of 28.90 is 92% below median its 10-year median of 352.96. Over the past 10 years, this metric has ranged from a low of 44.42 to a high of 26,864.00. The Biotechnology industry median Days Payable is 113.56. Regenerative Medical Technology Group's value of 28.90 is 74.6% below this industry median. Based on the distribution chart, Regenerative Medical Technology Group ranks #503 out of 704 companies in the Biotechnology industry, which is below the industry midpoint.
How does Regenerative Medical Technology Group's Days Payable compare to PTIX and CERO?
According to the Biotechnology industry distribution chart, Regenerative Medical Technology Group ranks #503 out of 704 companies for Days Payable. This places Regenerative Medical Technology Group in the lower half of its industry. The industry median Days Payable is 113.56. Regenerative Medical Technology Group's value of 28.90 is 74.6% below this benchmark. Historically, Regenerative Medical Technology Group's own Days Payable has ranged from 44.42 to 26,864.00 over the past decade. While the company's 10-year median is 352.96 vs. the industry median of 113.56, Regenerative Medical Technology Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Regenerative Medical Technology Group's current Days Payable of 28.90 is 74.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Regenerative Medical Technology Group and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regenerative Medical Technology Group's current Days Payable is 28.90, which is 92% below median its own 10-year median of 352.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regenerative Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Regenerative Medical Technology Group (RMTG) is currently considered Possible Value Trap. The stock's GF Value™ is $0.06, compared to a current price of $0.03 — trading 50.8% below its estimated fair value. The current Days Payable is 28.90, which is 92% below median its 10-year median of 352.96 and 74.6% below the Biotechnology industry median of 113.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Regenerative Medical Technology Group (RMTG), the current Days Payable is 28.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regenerative Medical Technology Group Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.